首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1701066

不孕症治療市場規模、佔有率、成長分析（按產品、治療程序、患者類型、最終用戶和地區）—2025 年至 2032 年行業預測

Infertility Treatment Market Size, Share, and Growth Analysis, By Product (Equipment, Media & Consumables), By Procedure (Assisted Reproductive Technology, Artificial Insemination), By Patient Type, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年04月02日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

不孕症治療市場規模預計到 2023 年將達到 38 億美元，從 2024 年的 40.6 億美元成長到 2032 年的 69.3 億美元，預測期內（2025-2032 年）的複合年成長率為 6.9%。

近年來，由於不孕症上升、孕婦人口老化、生活方式改變以及技術創新顯著等多種因素，全球不孕症治療市場迅速擴張。不孕症的流行影響了相當一部分人口，導致對有效治療方案的需求不斷增加。體外受精 (IVF) 和卵胞漿內單一精子注射 (ICSI) 等輔助生殖技術 (ART) 在面臨不孕症問題的夫妻中變得流行起來。這些技術的不斷進步正在提高成功率和患者的治療效果。隨著這些技術變得越來越普及和價格越來越便宜，市場預計將進一步成長。此外，第三方生殖方法接受度的提高、可支配收入的增加以及延遲生育的趨勢等因素也在推動市場發展。

市場概覽
輔助生殖技術
- 體外受精
- 卵細胞質內單一精蟲顯微注射術
- 代孕
人工授精
- 子宮內人工授精
- 子宮頸內授精
- 輸卵管內授精
不孕不育治療手術
- 腹腔鏡檢查
- 子宮鏡檢查
- 子宮肌瘤切除術
- 開放性手術
- 輸卵管結紮松解術
- 靜脈曲張切除術
- 顯微外科重組
- 血管吻合術
- 血管睪丸吻合術
其他生育手術

不孕症治療市場規模（按患者類型和複合年成長率） (2025-2032)

市場概覽
女性不孕症治療
男性不孕症治療

不孕症治療市場規模（按最終用戶和複合年成長率） (2025-2032)

市場概覽
不孕不孕治療中心
醫院和外科診所
精子庫
研究所

不孕症治療市場規模及複合年成長率（2025-2032）

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）
  主要企業簡介
  - CooperSurgical公司（美國）
  - Vitrolife（瑞典）
  - 富士膠片爾灣科學公司（日本）
  - 賽默飛世爾科技公司（美國）
  - 庫克醫療公司（美國）
  - 漢密爾頓索恩有限公司（美國）
  - Esco Micro 私人有限公司有限公司（新加坡）
  - Genea Biomedx（澳洲）
  - 默克集團（德國）
  - 輝凌製藥（瑞士）
  - Organon & Co.（美國）
  - 雅培實驗室（美國）
  - 諾華公司（瑞士）
  - 拜耳公司（德國）
  - 英迪拉體外受精（印度）
  - 費爾黑文健康（美國）
  - Theralogix（美國）
  - VitabIoTics Ltd.（英國）
  - Exeltis（西班牙）
  - 齊塔·韋斯特（英國）

結論和建議

簡介目錄

Product Code: SQMIG35D2204

Infertility Treatment Market size was valued at USD 3.8 billion in 2023 and is poised to grow from USD 4.06 billion in 2024 to USD 6.93 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The global infertility treatment market has surged in recent years, driven by rising infertility rates, advanced maternal age, lifestyle changes, and significant technological innovations. The prevalence of infertility affects a substantial portion of the population, leading to an increasing demand for effective treatment options. Assisted reproductive technologies (ART), such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have gained popularity among couples facing infertility challenges. Continuous advancements in these techniques have resulted in improved success rates and patient outcomes. The market is expected to grow further as these technologies become more accessible and affordable. Additionally, factors like the rising acceptance of third-party reproduction methods, increasing disposable incomes, and the trend of postponing parenthood are also driving market momentum.

Top-down and bottom-up approaches were used to estimate and validate the size of the Infertility Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Infertility Treatment Market Segments Analysis

Global Infertility Treatment Market is segmented by Product, Procedure, Patient Type, End User and region. Based on Product, the market is segmented into Equipment, Media & Consumables and Accessories. Based on Procedure, the market is segmented into Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries and Other Infertility Treatment Procedures. Based on Patient Type, the market is segmented into Female Infertility Treatment and Male Infertility Treatment. Based on End User, the market is segmented into Fertility Centers, Hospitals & Surgical Clinics, Cryobanks and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Infertility Treatment Market

The infertility treatment market is experiencing significant growth driven by several factors, including global increases in infertility rates attributed to lifestyle changes, delayed parenthood, and environmental factors. As more individuals and couples encounter fertility challenges, the demand for treatment options continues to rise. Moreover, advancements in medical technology, particularly in assisted reproductive techniques such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have notably improved success rates, rendering these treatments more effective and accessible. Consequently, the combination of rising infertility issues and enhanced technological capabilities is fueling the expansion of the infertility treatment market.

Restraints in the Infertility Treatment Market

A significant constraint in the infertility treatment market is the high cost associated with advanced therapies such as in vitro fertilization (IVF) and genetic testing. This financial burden limits access to these essential services for a large segment of the population. Additionally, ethical dilemmas related to assisted reproductive technologies-such as concerns over embryo manipulation and the moral considerations of surrogacy-add further complications that can hinder market growth. These factors collectively create barriers that impact the affordability and acceptance of infertility treatments, thereby restricting market expansion and accessibility for those in need.

Market Trends of the Infertility Treatment Market

The infertility treatment market is witnessing a significant trend characterized by rising consumer awareness and the growing utilization of precision medicine in approaches like in vitro fertilization (IVF). Advances in genetic testing and embryo screening have become essential, allowing for a more targeted and personalized selection process that increases the chances of successful implantation while minimizing genetic risks. Moreover, there is a notable shift toward the acceptance of third-party reproductive methods, such as surrogacy and gamete donation, which offer alternative pathways to parenthood. This increased openness is broadening the market's appeal and fostering innovative solutions for couples facing infertility challenges.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Regulatory Analysis
Technology Analysis

Global Infertility Treatment Market Size by Product & CAGR (2025-2032)

Market Overview
Equipment
- Microscopes
- Imaging Systems
- Sperm Analyzer Systems
- Ovum Aspiration Pumps
- Micromanipulator Systems
- Incubators
- Gas Analyzers
- Laser Systems
- Cryosystems
- Sperm Separation Devices
Media & Consumables
Accessories

Global Infertility Treatment Market Size by Procedure & CAGR (2025-2032)

Market Overview
Assisted Reproductive Technology
- In Vitro Fertilization
- Intracytoplasmic Sperm Injection
- Surrogacy
Artificial Insemination
- Intrauterine Insemination
- Intracervical Insemination
- Intratubal Insemination
Fertility Surgeries
- Laparoscopy
- Hysteroscopy
- Myomectomy
- Laparotomy
- Tubal Ligation Reversal
- Varicocelectomy
- Microsurgical Reconstruction
- Vasovasostomy
- Vasoepididymostomy
Other Infertility Treatment Procedures

Global Infertility Treatment Market Size by Patient Type & CAGR (2025-2032)

Market Overview
Female Infertility Treatment
Male Infertility Treatment

Global Infertility Treatment Market Size by End User & CAGR (2025-2032)

Market Overview
Fertility Centers
Hospitals & Surgical Clinics
Cryobanks
Research Institutes

Global Infertility Treatment Market Size & CAGR (2025-2032)

North America (Product, Procedure, Patient Type, End User)
- US
- Canada
Europe (Product, Procedure, Patient Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Procedure, Patient Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Procedure, Patient Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Procedure, Patient Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

CooperSurgical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitrolife (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Irvine Scientific (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Thorne Ltd. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Esco Micro Pte. Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genea Biomedx (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organon & Co. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indira IVF (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fairhaven Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Theralogix (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitabiotics Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exeltis (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zita West (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments